Clinical use of naltrexone (EN 1639 A). Part II: experience with the first 50 patients in a New York City treatment clinic.
D000284:Administration, Oral; D000553:Ambulatory Care; D004522:Educational Status; D004651:Employment; D005006:Ethnicity; D005260:Female; D006556:Heroin Dependence / Q000534:rehabilitation*; D006801:Humans; D008297:Male; D009270:Naloxone / Q000031:analogs & derivatives*; D009271:Naltrexone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D009519:New York City; D010352:Patient Dropouts
D009270:Naloxone; D009271:Naltrexone